Hedge Fund Trade Of The Week (CVS)

Anthony Scaramucci of Skybridge Capital is on CNBC's 'Fast Money' with his "Hedge Fund Trade Of The Week" and he said he likes CVS Caremark Corporation CVS.

Scaramucci said he sees it trading between $42-$46 per share over the next 12 to 18 months. Shares are trading around $33 per share.

Scaramucci said he sees major cost savings and upside potential in this name. The company has EBITDA of $8 billion, and should trade around 11 times EBITDA, which is where he gets his price target from.

Karen Finerman said that she thinks there is the potential for a split between the stores and the pharmacy benefit manager, PBM, sometime down the line, even though she sees the benefits of the merger. Scarcamucci agreed with her.

Scracamucci also said that he likes the name because other large names are in the stock as well. Greenblat, Soros, and Pennant also own the name.